FR2397192A1 - Inhibition par peptides de la fonction des gonades - Google Patents

Inhibition par peptides de la fonction des gonades

Info

Publication number
FR2397192A1
FR2397192A1 FR7820979A FR7820979A FR2397192A1 FR 2397192 A1 FR2397192 A1 FR 2397192A1 FR 7820979 A FR7820979 A FR 7820979A FR 7820979 A FR7820979 A FR 7820979A FR 2397192 A1 FR2397192 A1 FR 2397192A1
Authority
FR
France
Prior art keywords
mammals
trp
effective amount
peptides
inhibition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR7820979A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Salk Institute for Biological Studies
Original Assignee
Salk Institute for Biological Studies
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Salk Institute for Biological Studies filed Critical Salk Institute for Biological Studies
Publication of FR2397192A1 publication Critical patent/FR2397192A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/13—Luteinizing hormone-releasing hormone; related peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Inhibition par peptides de la fonction des gonades. L'invention propose un procédé de traitement de mammifères mâles pour empêcher la reproduction, selon lequel on administre au sujet une quantité efficace d'un peptide répondant à la structure p-Glu-His-Trp-Ser-Tyr-D-Trp-Leu-Arg-Pro-NH-CH 2 CH3 , un procédé de traitement de mammifères femelles pour empêcher la nidation d'oeufs, qui consiste à administrer au sujet une quantité efficace d'un peptique de même structure et un procédé de traitement de mammifères pour inhiber la libération de stéroïdes par les gonades, par quantité efficace d'un peptide répondant à la structure p-Glu-His-TrpSer-D-Trp-Leu-Arg-Pro-NH-CH2 -CH3 . Applicable aux mammifères en général.
FR7820979A 1977-07-14 1978-07-13 Inhibition par peptides de la fonction des gonades Withdrawn FR2397192A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81559077A 1977-07-14 1977-07-14
US05/917,781 US4218439A (en) 1977-07-14 1978-06-26 Peptide which inhibits gonadal function

Publications (1)

Publication Number Publication Date
FR2397192A1 true FR2397192A1 (fr) 1979-02-09

Family

ID=27123974

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7820979A Withdrawn FR2397192A1 (fr) 1977-07-14 1978-07-13 Inhibition par peptides de la fonction des gonades

Country Status (10)

Country Link
US (1) US4218439A (fr)
AU (1) AU519687B2 (fr)
CA (1) CA1110232A (fr)
CH (1) CH639362A5 (fr)
DE (1) DE2830629A1 (fr)
FR (1) FR2397192A1 (fr)
GB (1) GB2001077B (fr)
NL (1) NL7807612A (fr)
NZ (1) NZ187806A (fr)
SE (1) SE7807816L (fr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2905502C2 (de) * 1979-02-14 1982-07-15 Hoechst Ag, 6000 Frankfurt Verfahren zur Herstellung von LH-RH bzw. LH-RH-Analoga und Pyroglutamyl-N↑i↑m↑-dinitrophenyl-histidin
WO1982000004A1 (fr) * 1980-06-26 1982-01-07 Salk Inst For Biological Studi Traitement contraceptif des mammiferes males
US4377574A (en) * 1980-06-26 1983-03-22 The Salk Institute For Biological Studies Contraceptive treatment of male mammals
US4632979A (en) * 1984-06-18 1986-12-30 Tulane Educational Fund Therapeutic LHRH analogs
HU193607B (en) * 1985-07-18 1987-11-30 Innofinance Altalanos Innovaci Process for production of sexual products applyable for natural or artificial insemination for mammates
US4762717A (en) * 1986-03-21 1988-08-09 The General Hospital Corporation Continuous delivery of luteinizing hormone releasing hormone compositions in combination with sex steroid delivery for use as a contraceptive
US4975420A (en) * 1987-09-30 1990-12-04 University Of Saskatchewan Agents and procedures for provoking an immune response to GnRH and immuno sterilizing mammals
CA2029018A1 (fr) * 1989-11-01 1991-05-02 Robert P. Millar Analogues de l'hormone liberant de la gonadotrophine
US5084443A (en) * 1989-12-04 1992-01-28 Biomeasure, Inc. Promoting expression of acetylcholine receptors with lhrh antagonist
FR2713933B1 (fr) * 1993-12-16 1996-02-02 Rhone Merieux Méthode de superovulation des femelles bovines, méthode de mise en anoestrus et kit approprié.
AUPN366795A0 (en) * 1995-06-20 1995-07-13 Peptide Technology Limited Formulation for preventing reproductive function
CA2192773C (fr) 1995-12-15 2008-09-23 Hiroaki Okada Obtention d'une preparation a liberation prolongee pour injection
CA2192782C (fr) 1995-12-15 2008-10-14 Nobuyuki Takechi Production de microsphere
US20040265285A1 (en) * 1999-04-15 2004-12-30 Monash University Normalization of defective T cell responsiveness through manipulation of thymic regeneration
US20040258672A1 (en) * 1999-04-15 2004-12-23 Monash University Graft acceptance through manipulation of thymic regeneration
US20040259803A1 (en) * 1999-04-15 2004-12-23 Monash University Disease prevention by reactivation of the thymus
AUPR074500A0 (en) * 2000-10-13 2000-11-09 Monash University Treatment of t cell disorders
US20040241842A1 (en) * 1999-04-15 2004-12-02 Monash University Stimulation of thymus for vaccination development
US20050020524A1 (en) * 1999-04-15 2005-01-27 Monash University Hematopoietic stem cell gene therapy
US20070274946A1 (en) * 1999-04-15 2007-11-29 Norwood Immunoloty, Ltd. Tolerance to Graft Prior to Thymic Reactivation
US20060088512A1 (en) * 2001-10-15 2006-04-27 Monash University Treatment of T cell disorders
US20060287282A1 (en) * 2001-06-25 2006-12-21 Steiner Mitchell S Compositions comprising a SARM ad GnRH agonist or a GnRH antagonist, and methods of use thereof
WO2003041739A1 (fr) 2001-11-13 2003-05-22 Takeda Chemical Industries, Ltd. Agents anticancer
US20080279812A1 (en) * 2003-12-05 2008-11-13 Norwood Immunology, Ltd. Disease Prevention and Vaccination Prior to Thymic Reactivation
EP1701970A2 (fr) * 2003-12-31 2006-09-20 F.Hoffmann-La Roche Ag Procedes pour recuperer un peptide clive a partir d'un support
US8840956B2 (en) * 2008-10-31 2014-09-23 Potters Industries, Llc Retroreflective coating and method for applying a retroreflective coating on a structure
US20100272962A1 (en) * 2009-04-22 2010-10-28 Potters Industries Inc. Reflective substrate surface system, reflective assembly, and methods of improving the visibility of a substrate surface
US8647013B2 (en) * 2010-02-09 2014-02-11 Potters Industries, Llc Reflective substrate surface system, reflective assembly, and methods of improving the visibility of a substrate surface

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4034082A (en) * 1976-03-01 1977-07-05 Abbott Laboratories Method to prevent reproduction in warm-blooded female animals with nonapeptides

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3836640A (en) * 1972-04-28 1974-09-17 K Laurence Method for the chemical sterilization of male animals
US4081533A (en) * 1976-09-01 1978-03-28 Regents Of The University Of California Method of reducing mammalian fertility and drugs therefor

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4034082A (en) * 1976-03-01 1977-07-05 Abbott Laboratories Method to prevent reproduction in warm-blooded female animals with nonapeptides

Also Published As

Publication number Publication date
AU3792978A (en) 1980-01-17
CA1110232A (fr) 1981-10-06
DE2830629A1 (de) 1979-02-22
NZ187806A (en) 1984-10-19
NL7807612A (nl) 1979-01-16
SE7807816L (sv) 1979-01-15
GB2001077A (en) 1979-01-24
CH639362A5 (de) 1983-11-15
US4218439A (en) 1980-08-19
GB2001077B (en) 1982-02-24
AU519687B2 (en) 1981-12-17

Similar Documents

Publication Publication Date Title
FR2397192A1 (fr) Inhibition par peptides de la fonction des gonades
FI861150A (fi) Monoklonala antikroppar mot metallkelat.
DE69315847D1 (de) Verfahren zur behandlung einer durch lfa-1 vermittelten störung
DE3889536D1 (de) Behandlung von krebs mit somatostatin und mit analogen davon.
DE69201725D1 (de) Behandlungsmethoden für osteoporose.
Dubois et al. Gastrointestinal somatostatin cells in the human fetus
DE3684211D1 (fr)
ATE135578T1 (de) Verbesserung reproduktiver funktionen bei säugern
Relkin Effects of pinealectomy and constant light and darkness on thyrotropin levels in the pituitary and plasma of the rat
MA22915A1 (fr) Methodes de traitement de l'osteoporose pour utilisation de faibles doses de phosphonates.
KR860000867A (ko) 급성 방사선 증후군 발현억제 및 패혈증 발현억제의 방법 및 그 조성물
GB2109053B (en) Regulation of i.c. engine charging
FR2662744B1 (fr) Ensemble de reglage de la synchronisation des soupapes d'un moteur.
IE821855L (en) Glycerophosphocholines
NO830041L (no) Fremgangsmaate til behandling av azykli hos sauer eller storfe
EP0148025A3 (en) Antibodies and antibody-containing compositions for inhibiting periodontitis
ES501321A0 (es) Un metodo de preparacion de un peptido inhibidor de la liberacion de gonadotropinas por la glandula pituitaria en mamiferos.
ZA881596B (en) Composition and method for treatment of peptic ulcers
ZA851927B (en) Pharmaceutical composition containing 9alpha,11beta-dichloro-16alpha-methyl-21-oxycarbonyldicyclohexylmethyloxy preggna-1,4-diene-3,20-dione
GR3023977T3 (en) Somatotropin for increasing reproductivite performance in cattle.
GB1339737A (en) Diagnostic agents for primary hepatoma
FR2372156A1 (fr)
JPS5431147A (en) Elevator operating system
Cohen et al. Comparison of in vitro effects of anti-skin serum with antilymphocyte serum
JPS54157838A (en) Preventive for cerebral apoplexy

Legal Events

Date Code Title Description
ST Notification of lapse